Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2021 | The role of the gut microbiome and metabolome in GvHD susceptibility

Erik Orberg • 12 Dec 2021
ASH 2021
General

Erik Orberg, MD, PhD, University Hospital of the Technical University of Munich, Munich, Germany, provides an overview of findings from a longitudinal analysis of intestinal bacterial, viral and fungal populations in patients undergoing allogeneic stem cell transplantation. Bacterial and viral diversity were reduced in patients post-transplant, but fungal diversity was constant. Patients with graft-versus-host disease (GvHD) additionally had an increased loss of microbial diversity. Metabolite levels were also significantly affected post-transplant, and systemic antibiotic therapy was revealed to affect metabolite production and microbiome function. This interview took place at the 63rd ASH Annual Meeting and Exposition congress in Atlanta, GA.

More from Erik Orberg

3:25
Impact of microbiome signatures & production of intestinal metabolites on alloSCT outcomes
Erik Orberg • 28 Apr 2023
2:12
Establishing the link between intestinal metabolites and GvHD risk
Erik Orberg • 12 Dec 2021
1:21
Focusing on the fungal and viral microbiome in the transplant setting
Erik Orberg • 12 Dec 2021

Related Videos

4:07
Pooled fecal allogeneic microbiotherapy to treat refractory gastrointestinal acute GvHD
Florent Malard • 11 Apr 2024
5:23
Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD
Mohamad Mohty • 17 Apr 2024
2:00
HHV-6 reactivation after haploidentical transplantation with PTCy & ATG: incidence and risk factors
Rémy Duléry • 15 Apr 2024
1:41
The consequences of regulatory changes on access to devices and reagents needed for graft processing
Christian Chabannon • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals